Skip to content

The effect of calcium hydroxide and formocresol in root canal terapy in necrotic primary molars

comparison of clinical ,radiographical success rate and pain after using two endodontic treatment techniques in necrotic primary molars:a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
IRCT
Registry ID
IRCT20180521039763N1
Enrollment
80
Registered
2019-04-08
Start date
2017-04-21
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulp disease. Other diseases of pulp and periapical tissues

Interventions

Intervention 1: control group:placed calcium hydroxid in necrotic teeth. Intervention 2: Intervention group: placed formocresol in necrotic teeth.

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children aged 5 to 10 years without systemic and mental illness patients have at least one second molar necrosis the teeth have an abscess or sinus tract

Exclusion criteria

Exclusion criteria: the teeth can not be restored chamfer pulp floor is perforated the teeth have an internal or external analysis of more than one third of the root length

Design outcomes

Primary

MeasureTime frame
Assessing the success of radiography. Timepoint: 6 and 12 months after treatment. Method of measurement: Two dental practitioners who are not aware of the type of treatment will consider radiographic criteria (such as reducing the size of the lesion).;Assessing the success of clinicaly. Timepoint: 6 and 12 months after treatment. Method of measurement: Two dental practitioners who are not aware of the type of treatment will consider clinical criteria(Such as not sensitive to touch).

Secondary

MeasureTime frame
_. Timepoint: _. Method of measurement: _.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Jahanimoghadam

Kerman University of Medical Sciences

jahanimoghadam@kmu.ac.ir+98 34 3211 8071

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026